the HR+/HER2-low cell line ZR-75-1 was used as the basis for cell and animal models. The outcomes were compared with those of the HR+/HER2-0 cell line (T47D). The collective analysis revealed that while CDK4/6 inhibitor combined with endocrine therapy effectively suppressed the prolifera...
The responsiveness of the cells to knockdown of AKT was not affected by mutational status of p53 but appeared correlated with overexpression of HER2. To ... S Koseoglu,Z Lu,C Kumar,... - 《Cancer Biology & Therapy》 被引量: 172发表: 2007年 Cyclin D1, Id1 and EMT in breast cancer ...